BioLIMS 21 CFR Part 11 Compliance White Paper

1. 🔍 Introduction

In the era of digital transformation in life sciences, laboratories rely on electronic systems to manage data, execute workflows, and ensure product quality.To maintain integrity, authenticity, and traceability of electronic records and signatures, regulatory compliance with FDA 21 CFR Part 11 is a fundamental requirement.

💡 BioLIMS is purpose-built to support laboratories under GxP, GLP, and cGMP environments — ensuring that electronic records and signatures are as reliable and legally binding as paper-based documentation.It provides automation, security, and auditability at every step.

2. 📜 Understanding FDA 21 CFR Part 11

FDA 21 CFR Part 11 defines criteria for when electronic records and signatures are trustworthy, reliable, and equivalent to handwritten ones.

📘 Scope

Part 11 applies to:

• 💻 Electronic records used in regulated processes (R&D, clinical, manufacturing)

• ✍️ Electronic signatures replacing handwritten approvals

• 🗂️ Systems that create, modify, maintain, or transmit such records

🔑 Three Key Pillars

1. 🔒 System Security – Prevent unauthorized access or data tampering

2. 🕓 Audit Trail – Maintain secure, time-stamped, unalterable history

3. ✅ Electronic Signatures – Ensure digital sign-offs are unique, verifiable, and legally binding

3. 🧩 BioLIMS Compliance Framework

BioLIMS integrates Part 11 compliance into both technical architecture and operational controls.The platform is validated following GAMP5 and FDA Software Validation Principles, ensuring full traceability from requirements to deployment.

Regulatory Requirement	BioLIMS Compliance Feature
🔐 Access Control	Role-based access (RBAC), multi-factor authentication, session timeout
🧱 System Security	TLS 1.3 encryption, AES-256 data storage, tenant isolation
🕓 Audit Trail	Immutable logs of all create/edit/delete events with user, timestamp, and reason
✍️ Electronic Signature	Bound to user ID, password re-verification, cryptographic linkage
🧬 Data Integrity	Original data preserved; all edits versioned with justification
🔁 Version Control	Automatic versioning for templates, workflows, SOPs, and reports
🔄 Change Control	All configuration and software updates validated and documented
🧾 System Validation	IQ/OQ/PQ protocols with traceability matrix
💾 Backup & Retention	Automated encrypted backups, configurable retention policies
🎓 Training & SOPs	Permissions linked to training; audit-ready records

4. 🧪 Software Validation and Documentation

BioLIMS complies with FDA’s “General Principles of Software Validation” (2002) and GAMP5 best practices.

📄 Validation Deliverables

• 🗂️ Validation Plan (VP) – Scope, strategy, and responsibilities

• 📋 User Requirements (URS) – Mapped to 21 CFR Part 11 clauses

• ⚙️ Functional & Design Specifications (FS/DS)

• 🧭 Risk Assessment (RA) – Identify and mitigate compliance risks

• 💻 Installation Qualification (IQ) – Verify proper setup

• 🧰 Operational Qualification (OQ) – Confirm system operates as intended

• 📈 Performance Qualification (PQ) – Validate performance under real use

• 🧾 Validation Summary Report (VSR) – Summarize compliance evidence

🧩 BioLIMS provides a complete Validation Package for client-side User Site Validation per FDA requirements.

5. ☁️ Continuous Compliance and Cloud Infrastructure

BioLIMS runs on a secure, cloud-native architecture tailored for regulated environments.

🚀 Key Features

• 🌍 Multi-region deployment on AWS / Azure / Google Cloud (US, EU, China options)

• 🔁 Continuous Validation ensuring all updates remain validated and traceable

• ⚡ Zero-downtime upgrades with automated regression testing

• 📜 Audit-ready environments with logs and configuration history retained for inspection

Each update undergoes automated testing, validation review, and documented approval before release.

6. 🤝 Responsibilities: Vendor & User

FDA defines shared responsibility for Part 11 compliance:

Responsibility	Description	Party
🧠 Software Design & Validation	Develop and validate system; provide documentation	BioLIMS Vendor
🧩 System Configuration & Usage Validation	Validate within user’s environment (IQ/OQ/PQ)	BioLIMS / User Org.
🧾 Policies, SOPs & Training	Maintain procedures, control access, document training	User Org. / BioLIMS

BioLIMS Support Includes:

• 🧱 Standardized validation templates

• 📚 Preconfigured SOP samples

• 🔍 Audit preparation guidance

• 💬 Compliance consulting services

7. 🧭 Data Integrity and GxP Readiness

BioLIMS is built on ALCOA+ principles:Attributable · Legible · Contemporaneous · Original · Accurate · Complete · Consistent · Enduring · Available

📊 All records — raw data, metadata, audit logs — are tamper-proof and version-controlled.BioLIMS fully supports GxP, GLP, GMP, and GDP operations and integrates with regulated systems via secure APIs with full traceability.

8. 🛡️ Compliance Statement

BioLIMS is developed, validated, and maintained in alignment with:

• FDA 21 CFR Part 11

• GAMP5

• Global Data Integrity Standards

It provides:

• 🔒 Secure user authentication

• 🕓 Complete audit trails

• ✍️ Cryptographically bound electronic signatures

All designed to ensure regulatory-grade compliance.Users remain responsible for their procedures, validation, and site documentation.

9. 🌟 Conclusion

BioLIMS offers a comprehensive, validated, and audit-ready platform for FDA and global compliance.With its cloud-native agility and regulatory precision, BioLIMS enables life science organizations to digitize workflows confidently — maintaining data integrity, security, and validation assurance.

💠 BioLIMS: Compliant · Secure · Ready for Inspection

10. 📚 Appendix — Supporting References

• 📘 FDA 21 CFR Part 11 — Electronic Records; Electronic Signatures

• 🧾 FDA Guidance — Part 11, Scope and Application

• 📄 FDA — General Principles of Software Validation (2002)

• 🧠 ISPE GAMP5 — Risk-Based Approach to Compliant GxP Systems (2nd Ed., 2022)

• 🧩 EMA Annex 11 — Computerised Systems

• 🌐 ISO 27001 · ISO 9001 · ISO 13485